Rilzabrutinib (Wayrilz; Sanofi), a BTK inhibitor, targets immune-mediated platelet destruction in immune thrombocytopenia (ITP) and has demonstrated a favorable safety profile.

Researchers from Miguel Hernández University of Elche (UMH) in Spain have identified an effective strategy to reduce structural liver damage and improve hepatic vascular function in cirrhosis. The ...

Pyrrolizidine alkaloids (PAs), widely distributed in plants, are known to induce liver failure. Hepatic platelet accumulation has been reported during the progression of PA-induced liver injury ...

The China National Medical Products Administration has approved Dova Pharmaceuticals' Doptelet (avatrombopag) for chronic liver disease patients with thrombocytopenia (low blood platelets) who are ...

MUSCAT: The Ministry of Health (MoH) has issued an urgent appeal for O positive platelet donations to save the life of a ...

Medically reviewed by Doru Paul, MD Key Takeaways Low platelets can occur when your bone marrow doesn't make enough platelets ...

Muscat: The Ministry of Health (MoH) appealed for the immediate donation of O positive platelets to help save the life of a ...

What can you tell me about the cause and treatment of immune thrombocytopenia purpura (ITP)? I am a 71-year-old male, and ...

What can you tell me about the cause and treatment of immune thrombocytopenia purpura (ITP)? I am a 71-year-old male, and after lab results showed a low ...